Boussard & Gavaudan Gestion Sas Makes New $2.60 Million Investment in Integer Holdings Corporation $ITGR

Boussard & Gavaudan Gestion Sas bought a new position in Integer Holdings Corporation (NYSE:ITGR) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 28,153 shares of the medical equipment provider’s stock, valued at approximately $2,597,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in Integer during the 2nd quarter worth $29,000. EverSource Wealth Advisors LLC grew its stake in Integer by 48.1% in the first quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock valued at $32,000 after acquiring an additional 117 shares during the period. TD Private Client Wealth LLC increased its holdings in shares of Integer by 1,037.5% in the fourth quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock worth $36,000 after acquiring an additional 415 shares in the last quarter. Parkside Financial Bank & Trust increased its holdings in shares of Integer by 135.5% in the fourth quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after acquiring an additional 267 shares in the last quarter. Finally, Arax Advisory Partners raised its position in shares of Integer by 2,489.5% during the fourth quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 473 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Benchmark lowered Integer from a “buy” rating to a “hold” rating in a research report on Thursday, August 13th. HC Wainwright restated a “buy” rating on shares of Integer in a report on Friday, July 24th. Zacks Research raised shares of Integer from a “strong sell” rating to a “hold” rating in a research note on Monday, July 20th. Raymond James Financial cut shares of Integer from a “moderate buy” rating to a “hold” rating in a report on Monday, August 3rd. Finally, Freedom Capital lowered shares of Integer from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 4th. One investment analyst has rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $109.86.

Integer Stock Performance

Shares of ITGR opened at $125.30 on Friday. The stock has a market capitalization of $4.26 billion, a price-to-earnings ratio of 34.24, a PEG ratio of 2.96 and a beta of 0.61. Integer Holdings Corporation has a 12 month low of $62.00 and a 12 month high of $126.14. The firm has a fifty day simple moving average of $107.58 and a 200 day simple moving average of $94.48. The company has a current ratio of 3.73, a quick ratio of 2.41 and a debt-to-equity ratio of 0.75.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.38 by $0.22. Integer had a net margin of 6.97% and a return on equity of 12.79%. The firm had revenue of $464.11 million for the quarter, compared to analyst estimates of $451.07 million. During the same period in the previous year, the business earned $1.55 EPS. The company’s revenue was down 2.6% compared to the same quarter last year. Research analysts forecast that Integer Holdings Corporation will post 6.09 EPS for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.